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The tree-like architecture of the mammary gland is generated by branching morphogenesis, which is
regulated by many signals from the microenvironment. Here we examined how signaling downstream of
phosphoinositide 3-kinase (PI3K) regulates different steps of mammary branching using three-
dimensional culture models of the mammary epithelial duct. We found that PI3K was required for both
branch initiation and elongation. Activated Akt was enhanced at branch initiation sites where its negative
regulator, PTEN, was blocked by signaling via Sprouty2 (SPRY2); inhibiting Akt prevented branch
initiation. The pattern of SPRY2 expression, and thus of Akt activation and branch initiation, was
controlled by mechanical signaling from endogenous cytoskeletal contractility. In contrast, activated
GTP-bound Rac1 localized to the leading edge of nascent branches and was required for branch
elongation. These data suggest that the PI3K network integrates mechanical and biochemical signaling
to control branching morphogenesis of mammary epithelial cells.
& 2013 Elsevier Inc. All rights reserved.Introduction
Ramiﬁed epithelia such as the mammary gland develop via
branching morphogenesis, which generates functionally efﬁcient,
complex, but well-ordered tissue architectures (Hogan, 1999).
Epithelial branching morphogenesis is a reiterative process that
can be divided into several unique steps, including primary bud
formation, branch initiation, and branch elongation (Affolter et al.,
2003; Zhu and Nelson, 2012). During branching of the murine
mammary gland, terminal end buds (TEBs) form at the tips of the
ducts and invade into the surrounding stroma in response to
stimulation from ovarian hormones. New primary branches then
form through bifurcation of the TEBs and secondary side branches
sprout laterally from the primary ducts. This process is reiterated
until the entire mammary fatpad is ﬁlled with the epithelial tree
(Sternlicht, 2006).
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son).thereof (Affolter et al., 2003; Zhang and Vande Woude, 2003; Zhu
and Nelson, 2012). These cellular level processes are regulated by
different signals including hormones, growth factors, receptor
tyrosine kinases (RTKs), extracellular matrix (ECM) molecules,
and endogenous mechanical stress (Gjorevski and Nelson, 2011;
Metzger and Krasnow, 1999). The phosphoinositide 3-kinase
(PI3K)/Akt signaling network can be activated by several RTKs to
regulate a wide array of cellular functions (Martelli et al., 2006).
Upon activation by growth factor stimulation, PI3K produces the
lipid second messenger phosphatidylinositol-3,4,5-trisphosphate
(PtdIns(3,4,5)P2, PIP3), which in turn binds to the serine/threonine
protein kinase Akt (Matsui et al., 2003), recruiting it to the
membrane for subsequent activation by phosphorylation. Akt
regulates a variety of transcription factors as well as several
cytoplasmic proteins (Manning and Cantley, 2007). For example,
Akt promotes cell invasion by increasing the production of matrix
metalloproteinase-9 (MMP9) (Kim et al., 2001) and modulates cell
migration by phosphorylating p21-activated kinase (PAK) (Zhou
et al., 2003).
In normal tissue, PI3K signaling can be attenuated by PTEN, a
ubiquitously expressed tumor suppressor protein that depho-
sphorylates PIP3 into PIP2 (Polak and Buitenhuis, 2012). PTEN is
subject to regulation at the transcriptional level, as well as at the
post-translational level by phosphorylation (Tamguney and
Stokoe, 2007). The phosphorylated carboxy terminal tail of PTEN
interacts with its catalytic domain, serving as a pseudosubstrate
and therefore causing auto-inhibition (Odriozola et al., 2007;
Tamguney and Stokoe, 2007). One of the proteins that regulates
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sphorylation of PTEN at several sites, increasing its activity and
thereby decreasing PI3K signaling (Edwin et al., 2006).
This regulation of the PI3K pathway is potentially relevant for
branching morphogenesis. SPRY2 encodes an RTK inhibitor
(Hacohen et al., 1998; Kramer et al., 1999), and was ﬁrst identiﬁed
as a novel antagonist of ﬁbroblast growth factor (FGF) signaling
during development of the Drosophila trachea. In SPRY mutants,
overactivation of the FGF pathway induces ectopic branching from
the stalks of the primary trachea (Hacohen et al., 1998). SPRY2
similarly acts as a negative regulator of branching morphogenesis
in several other organs. Targeted overexpression of SPRY2 in
mouse peripheral lung epithelium using the surfactant protein-C
(SP-C) promoter reduces branching and inhibits epithelial prolif-
eration (Mailleux et al., 2001). Conversely, transiently reducing the
levels of SPRY2 in cultured mouse lung explants results in a
dramatic increase in branching as well as in the expression of
lung epithelial marker genes (Tefft et al., 1999). Consistently,
tissue-speciﬁc overexpression of SPRY2 in the ureteric bud causes
severe defects in kidney development including a reduction in
organ size owing to inhibition of ureteric branching (Chi et al.,
2004). SPRY2 is thus considered as a negative regulator of
branching morphogenesis (Mailleux et al., 2001; Tefft et al.,
1999) and is well poised to modulate PI3K signaling via PTEN.
Whereas the PI3K pathway has also been implicated in branch-
ing of the mammary gland (Li et al., 2002; Renner et al., 2008;
Utermark et al., 2012), it remains unclear what downstream
signals are involved in the regulation of the different steps of the
branching process. Conditional deletion of PTEN in the mouse
mammary gland via the use of MMTV-Cre leads to accelerated
ductal extension and enhanced lateral branching during puberty
(Li et al., 2002). Similarly, MMTV-mediated transgenic expression
of an activated myristoylated p110α protein, the catalytic subunit
of PI3K, leads to increased ductal branching (Renner et al., 2008).
In addition to Akt, PI3K activates Rac1 (Kolsch et al., 2008), which
promotes the formation of lamellipodia (Ridley et al., 1992) and
induces the expression of various MMPs (Mack et al., 2011), which
are themselves required for mammary branching morphogenesis
(Fata et al., 2007; Simian et al., 2001; Wiseman et al., 2003). PI3K is
thus considered to be a positive regulator of branching by
mammary epithelial cells (Zhu and Nelson, 2012).
Here we used organotypic culture models to characterize how
signaling downstream of PI3K regulates the branch initiation and
extension steps of mammary epithelial branching morphogenesis.
We found that Akt is required for branch initiation downstream of
growth factor signaling, and its activity is controlled by the levels
of phosphorylated PTEN. In contrast, activated Rac1 found at the tips
of the branches is required for branch elongation. Phosphorylated
PTEN and Akt are regulated by endogenous mechanical stress, which
signals through SPRY2. Therefore, the PI3K pathway couples mechan-
ical signaling and biochemical signaling in its regulation of branching
morphogenesis by mammary epithelial cells.Materials and methods
Cell culture and reagents
Functionally normal EpH4 mouse mammary epithelial cells were
cultured in DMEM/F12 growth medium (Hyclone) supplemented
with 2% heat-inactivated fetal bovine serum (FBS; Atlanta Biologi-
cals), 50 mg/ml gentamicin (Sigma), and 5 mg/ml insulin (Sigma).
NMuMG mouse mammary epithelial cells (ATCC) were cultured in
DMEM supplemented with 10% FBS, 50 μg/ml gentamicin, and 10 μg/
ml insulin. EpH4 and NMuMG cells have been widely used in studies
of mammary epithelial branching morphogenesis. Cells were grownin a 37 1C incubator with 5% CO2 and treated with the following
reagents diluted to the concentrations indicated: LY294002 (50 μM;
Cell Signaling); wortmannin (1 μM; Cell Signaling); Akt inhibitor
IV (5-(2-benzothiazolyl)-3-ethyl-2-[2-(methylphenylamino)ethenyl]-
1-phenyl-1 H-benzimidazolium iodide, 20 μM; EMD Millipore);
Y27632 (10 μM; Tocris); blebbistatin (25 μM; Sigma); calyculin A
(0.5 nM; Calbiochem); NSC23766 (100 μM; Tocris).
shRNA and expression constructs
shRNAs targeting the Mus musculus sequence of SPRY2
(NM_011897) were purchased from Open Biosystems (Table S1).
Control scrambled shRNA (Sarbassov et al., 2005), constitutively
active PI3K plasmid pCAG-Myr-p110-IH (Takahashi et al., 2003),
and control plasmid pCAGEN (Matsuda and Cepko, 2004) were
obtained from AddGene.
Transfections
One day before transfection, cells were seeded in 10-cm dishes
at 60–70% conﬂuence. The following day, transfections were
performed using 10 μg of each relevant plasmid and SuperFect
Transfection Reagent (Qiagen).
Preparation and branching of cell clusters
Clusters of mouse mammary epithelial cells were prepared by
overnight shaking (180 rpm at 37 1C for 15 h) in the presence of
0.083% (w/v) of pluronic F108 (BASF) as previously described (Lee
et al., 2011). Cell clusters ∼100 mm in diameter were collected by
centrifugation (200 rpm for 1 min) and embedded within 4 mg/ml
of non-pepsinized native type I collagen (Koken), which was gelled
as described previously (Pavlovich et al., 2011). A cell-free layer of
collagen was placed underneath the layer containing clusters.
Growth medium including no growth factor, EGF (4.2 nM, Invitro-
gen), or HGF (4.2 nM, Sigma) was added to the samples to induce
branching.
Engineered mammary epithelial tubules
Elastomeric stamps of poly(dimethylsiloxane) (PDMS; Sylgard
184, Ellsworth Adhesives) containing a relief of the desired tissue
geometry were fabricated using a combination of photolithogra-
phy and soft lithography (Gomez and Nelson, 2011; Nelson et al.,
2008). Brieﬂy, stamps were rendered non-adhesive by coating
with 1% (w/v) bovine serum albumin in phosphate-buffered saline
(PBS). Stamps were placed atop a drop of collagen, which was then
gelled as described above. After removing the stamps, a suspen-
sion of mammary epithelial cells was allowed to settle within the
molded collagen cavities. Any extra cells were washed away with
growth medium and a gelled collagen lid was placed on top of the
sample. The epithelial cells formed cylindrical tissues of the shape
and size of the collagen cavities, and remained quiescent until
induced to branch by addition of medium containing EGF or HGF.
Imaging and immunoﬂuorescence analysis
The branching pattern of microfabricated tubules was mea-
sured as described previously (Nelson et al., 2006). Brieﬂy, samples
were ﬁxed in 4% paraformaldehyde for 15 min, stained for nuclei
using Hoechst 33342 (Invitrogen), and visualized using a Hama-
matsu Orca CCD camera attached to a Nikon Eclipse Ti microscope.
The binarized images of 50 tubules were stacked with ImageJ
software to obtain a pixel frequency map, which was subsequently
color-coded in Adobe Photoshop.
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bilized (0.5% Igepal CA-630 for 10 min, then 0.1% Triton X-100 in
PBS for 15 min), and blocked with 10% goat serum (Atlanta
Biologicals) overnight. Samples were then incubated with primary
antibodies against pAkt (Cell Signaling), pPTEN (Sigma), or cleaved
caspase-3 (Cell Signaling), followed by incubation with Alexa
Fluor-conjugated secondary antibodies (Invitrogen). Signal inten-
sity as a function of spatial location was measured by taking a line
scan through the midline of each tubule, and the end/middle ratio
was calculated by dividing the signal intensity at the two ends by
the signal intensity in the middle.
To visualize active GTP-bound Rac1, samples were ﬁxed and
permeabilized as described above. After blocking with 10% goat
serum, the tissues were incubated with GST-PAK-PBD (Cytoskele-
ton) (ﬁnal concentration 2.5 mg/100 ml of blocking solution) over-
night, followed by rabbit anti-GST antibody (Sigma) and secondary
goat anti-rabbit antibody.
Immunoblotting
Whole cell lysates were prepared from mammary epithelial
cells transfected with pCAG-Myr-p110-IH or pCAGEN control
(AddGene) using RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.1%
SDS, 0.5% sodium deoxycholate, 50 mM Tris, pH 8.0, and protease
inhibitor cocktail). Immunoblot analysis was performed using
antibodies against p110α (Cell Signaling), pAkt (Cell Signaling),
Akt (Cell Signaling), pPTEN (Sigma), PTEN (Sigma), SPRY2 (Abcam)
or β-actin (Cell Signaling).
Statistical analysis
All experiments were conducted independently at least three
times. The Student's t-test was used to compare branch lengths
and the percentage of branching clusters between conditions.
P valueso0.05 were considered to be statistically signiﬁcant.Results
The PI3K pathway is required for branching morphogenesis of
mammary epithelial cells
We used two complementary three-dimensional (3D) culture
models to recapitulate the mammary epithelium and investigate
the role of the PI3K pathway in the multi-step process of branch-
ing morphogenesis. In the ﬁrst model, clusters of EpH4 mouse
mammary epithelial cells were embedded within 3D ECM gels of
type I collagen (Chen et al., 2009; Hirai et al., 1998; Lee et al., 2011;
Pavlovich et al., 2011; Simian et al., 2001). Robust branching
morphogenesis occurred after the addition of epidermal growth
factor (EGF) or hepatocyte growth factor (HGF) (Fig. 1A and B).
These branches were multicellular in morphology and extended
up to 100 μm into the surrounding collagen gel, as reported by
several previous studies using this system (Chen et al., 2009; Hirai
et al., 2007; Lee et al., 2011; Mori et al., 2013; Simian et al., 2001).
Strikingly, we observed that branching was completely blocked in
the presence of 50 mM LY294002 or 1 mM wortmannin (Fig. 1A and
B), both of which are potent inhibitors of PI3K (Walker et al.,
2000). We observed similar results in clusters of NMuMG mouse
mammary epithelial cells (Fig. S1), a widely used model for the
mammary epithelium (Owens et al., 1974).
In the second 3D culture system, mammary epithelial tubules
of speciﬁc and reproducible pre-deﬁned geometries were engi-
neered within collagen gels using replica micromolding (Gjorevski
and Nelson, 2010, 2012; Lee et al., 2011; Nelson et al., 2006, 2008;
Pavlovich et al., 2011). When treated with HGF, branches formedspeciﬁcally at the ends of cylindrical tubules (Fig. 1C and D).
Consistent with the results in 3D clusters, branching morphogen-
esis of the engineered tubules was blocked in the presence of
LY294002 or wortmannin (Fig. 1C and D). Together, these results
suggest that the PI3K pathway is necessary for mammary epithe-
lial cells to branch in response to either EGF or HGF.
Inhibiting Akt blocks branching morphogenesis of mammary
epithelial cells
The PI3K pathway regulates divergent physiological processes
that include cell proliferation, growth, differentiation, apoptosis,
metabolism, and motility (Martelli et al., 2006). Many of these
functions relate to the ability of PI3K to lead to activation of the
serine/threonine kinase, Akt (Engelman, 2009). Akt thus acts as a
critical signaling node downstream of PI3K.
To explore the role of downstream effectors of PI3K in the
regulation of branching of mammary epithelial cells, we ﬁrst
disrupted the activity of Akt using a benzimidazole-derivative
pharmacological inhibitor. Branching morphogenesis was evaluated
using both the 3D cluster and engineered tubule assays, as
described above. In both assays, branching was blocked in the
presence of the Akt inhibitor (Fig. 2A and B; Fig. S1). To conﬁrm that
PI3K regulates branching of mammary epithelial cells via Akt, we
expressed ectopically an activated form of the p110α subunit of PI3K
while simultaneously disrupting Akt activity with the pharmacolo-
gical inhibitor. Expression of activated p110α was conﬁrmed by
immunoblotting analysis (Fig. 2C). Surprisingly, expression of acti-
vated p110α was not sufﬁcient, by itself, to induce branching in the
absence of treatment with growth factors (Fig. 2D). However, when
induced to branch, tubules expressing activated p110α extended
branches that were signiﬁcantly longer than those of controls
(Fig. 2E). The initiation of these branches was completely blocked
when tubules expressing activated p110α were treated with the Akt
inhibitor (Fig. 2D). These data suggest that activation of Akt is
required for PI3K-mediated branching morphogenesis of mammary
epithelial cells.
Akt is activated by HGF and phosphorylated Akt (pAkt) is sustained at
future branch sites
One advantage of the engineered tubule assay is that the initial
geometry of the tubules is tightly controlled and the positions at
which they branch are highly predictable and reproducible. This
predictability permits examination of the signals that inﬂuence
branching within the tissues at time points before branches have
initiated. In the cylindrical tubules, branches initiate speciﬁcally at
the two ends. That the Akt inhibitor completely blocked branching
led us to examine the spatial distribution of activated Akt, which is
characterized by phosphorylation at its carboxy terminal tail (Yang
et al., 2002). Immunoﬂuorescence analysis revealed that the
phosphorylation of Akt increased rapidly and homogeneously
throughout the mammary epithelial tubules within 30 min after
treatment with HGF (Fig. 3A). At 2 h after induction with HGF, the
pAkt signal in the body of the tubules had decreased, whereas the
signal at the ends of the tubules was sustained (Fig. 3A and B).
By contrast, total Akt was evenly distributed throughout the
tubules (Fig. 3C). At this time point, we also observed that cells
at the ends of the tubules had formed lamellipodia that projected
out into the surrounding collagen (Fig. 3A, arrow). Thereafter, the
pAkt signal gradually decreased and had reduced to background
levels by 4 h after addition of growth factor (Fig. 3A).
PTEN is the primary inhibitory regulator of Akt phosphoryla-
tion and the PI3K pathway. Phosphorylation of PTEN decreases its
membrane localization and activity (Tamguney and Stokoe, 2007).
To investigate how the spatial distribution of pAkt is regulated,
Fig. 1. Branching morphogenesis induced by EGF or HGF is blocked by PI3K inhibitors. (A) Clusters of mammary epithelial cells were embedded in collagen gel and treated
with no growth factor (No GF), EGF or HGF with or without PI3K inhibitors and monitored for branching after 24 h. Shown are phase contrast and ﬂuorescence images
depicting nuclei (blue) and actin (green). Scale bars, 100 mm. (B) Branching in the cluster assay was quantiﬁed by counting the percentage of clusters that branched in each
well. nIndicates po0.05 compared with No GF control. (C, D) Mammary epithelial tubules were treated with No GF or HGF with or without LY294002 (C) or wortmannin
(D) for 24 h. Shown are phase contrast images and frequency maps of 50 tubules stained for nuclei. Scale bars, 50 mm. Color bars indicate frequency.
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tubules. We found that pPTEN was also enhanced in the cells
located at the ends of the tubules (Fig. 3D), which was similar to
the spatial distribution of pAkt. In contrast, total PTEN showed an
even distribution within the tubules (Fig. 3E). These data suggest
that a local reduction in PTEN activity at the ends of the tubules
leads to enhanced phosphorylation and activation of Akt, thus
permitting branch initiation.
High mechanical stress at the ends of the tubules sustains activation
of the PI3K pathway
The mechanical properties of the microenvironment have been
shown to alter activation of the PI3K pathway (Hoshino et al.,
2007; Rice et al., 2010). Shear stress activates Akt and Akt-related
signaling proteins in vascular smooth muscle cells and this
activation is closely correlated with shear-induced vascular
smooth muscle cell reorientation (Rice et al., 2010). When bovine
aortic endothelial cells are exposed to cyclic strain, the levels of
pPTEN and pAkt increase in a time-dependent manner (Hoshino
et al., 2007). We found previously that mechanical stress is
distributed non-uniformly across engineered epithelial tissues,
with higher stress concentrated at the ends of the tubules(Gjorevski and Nelson, 2010, 2012). These observations led us to
hypothesize that the high mechanical stress at the ends of the
tubules was responsible for the locally sustained activation of the
PI3K pathway. To explore this possibility, we modulated cytoske-
letal contractility to perturb the endogenous mechanical stress
proﬁle within the tissue. Contractility of the actin cytoskeleton is
enhanced by signaling through the Rho effector, Rho kinase
(ROCK) and phosphorylation of myosin light chain. Treatment
with either Y27632, which inhibits the activity of ROCK (Davies
et al., 2000), or with blebbistatin, a small molecule inhibitor of
non-muscle myosin II (Kovacs et al., 2004), reduce actomyosin-
mediated contractility and thus mechanical stress at the ends of
the engineered tubules (Gjorevski and Nelson, 2010). In vehicle-
treated control samples, we observed elevated levels of pAkt and
pPTEN at the ends of the tubules (Fig. 4A–C). However, treatment
with either blebbistatin or Y27632 led to a homogenous distribu-
tion of both pAkt (Fig. 4A and B) and pPTEN (Fig. 4A and C) with
the tubules. Conversely, increasing contractility with the myosin
light chain phosphatase inhibitor calyculin A (Ishihara et al., 1989)
led to an increase in the relative levels of pAkt at the ends of the
tubules (Fig. S2). These data suggest that the spatial distributions
of pAkt and pPTEN are regulated in part by endogenous mechan-
ical stress within the epithelial tissues.
Fig. 2. Inhibiting Akt blocks branching morphogenesis of mammary epithelial cells. (A) Clusters of mammary epithelial cells were embedded in collagen gel and treated with
no growth factor (No GF), EGF or HGF with or without Akt inhibitor (20 mM) and monitored for branching after 24 h. Shown are phase contrast and ﬂuorescence images
depicting nuclei (blue) and actin (green). Scale bars, 100 mm. (B) Mammary epithelial tubules were treated with No GF or HGF with or without Akt inhibitor for 24 h. Shown
are phase contrast images and frequency maps of 50 tubules stained for nuclei. Scale bars, 50 mm. Color bars indicate frequency. (C) Mammary epithelial cells were
transfected with pCAGEN control vector or pCAG-Myr-p110-IH plasmid. Total protein was assessed by immunoblotting to determine the expression levels of p110α, pAkt,
total Akt, and β-actin. (D) Transfected mammary epithelial cells were used to form tubules, which were treated with No GF or HGF with or without Akt inhibitor for 24 h.
Shown are phase contrast images and frequency maps of 50 tubules stained for nuclei. Scale bars, 50 mm. Color bars indicate frequency. E. Quantiﬁcation of branch lengths
from engineered tubules transfected with pCAGEN or pCAG-Myr-p110-IH plasmid. *po0.05.
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during branching morphogenesis of mammary epithelial cells
Previous studies have suggested that SPRY2 negatively regu-
lates branching morphogenesis of the Drosophila trachea and
several mammalian organs (Hacohen et al., 1998; Mailleux et al.,
2001; Tefft et al., 1999). We were able to conﬁrm a similar
inhibitory role for SPRY2 in our 3D culture model. Small hairpin
RNA (shRNA)-mediated knockdown of SPRY2 (shSPRY2) in mouse
mammary epithelial cells led to ectopic and unpatternedbranching along the entire length of the tubules (Fig. S3). SPRY2
has been reported to lead to dephosphorylation of the inhibitory
phosphates on the carboxy terminus of PTEN, thereby increasing
PTEN levels and activity (Edwin et al., 2006). Indeed, we found
that shRNA-mediated knockdown of SPRY2 increased the levels of
pPTEN and pAkt (Fig. 5A). We therefore sought to determine
whether SPRY2 affects the spatial distribution of pPTEN and pAkt
within the 3D engineered tissues. Tubules comprised of mammary
epithelial cells expressing shSPRY2, but not scrambled shRNA,
showed higher relative levels of pAkt and pPTEN when treated
Fig. 3. pAkt and pPTEN are sustained at future branch sites. (A) Tubules were treated with HGF for different time periods and stained for pAkt. Scale bars, 50 mm.
(B) Frequency map of 50 tubules stained for pAkt after 2 h of treatment with HGF. (C-E) Immunoﬂuorescence images and frequency maps of 50 tubules stained for total Akt
(C), phosphorylated PTEN (D) or total PTEN (E) after 2 h of treatment with HGF. Scale bars, 50 mm. Color bars indicate frequency.
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second set of SPRY2-speciﬁc shRNAs (Fig. S4). These results
suggest that SPRY2 blocks mammary epithelial branching mor-
phogenesis in part by activating PTEN and thus inhibiting PI3K
signaling along the trunk of the tissue.
Inhibiting Rac1 blocks branch extension
Our data revealed that Akt was activated soon after growth
factor stimulation to promote branch initiation, and that the pAkt
signal reduced to background levels after about 4 h, suggesting
that signaling through effectors other than Akt were responsible
for branch elongation. In addition to Akt, Rac1 has been implicated
as a key effector downstream of PI3K (Kolsch et al., 2008). To
investigate the role of Rac1 in the regulation of mammary
branching by PI3K, we treated mammary epithelial tubules with
the Rac inhibitor NSC23766, which prevents Rac1 activation by
Rac-speciﬁc guanine nucleotide exchange factors (GEFs) without
affecting the activation of Cdc42 or RhoA (Nassar et al., 2006).
Treatment with NSC23766 did not completely block branching
from the tubules, but instead signiﬁcantly reduced the lengths of
the branches that formed (Fig. 6A). We obtained similar results
using the 3D cluster assay (Fig. 6B and C; Fig. S1). These data
suggest that activation of Rac1 is required for growth factor-
stimulated branch extension, but not branch initiation.
Our experiments showed that inhibiting Akt prevented branch-
ing completely whereas inhibiting Rac1 permitted branch initia-
tion but prevented branch extension. These ﬁndings, along with
the evidence that the activation of Akt reduced to background
levels within 4 h of growth factor stimulation, led us to hypothe-
size that PI3K regulates branch extension through Rac1. To test this
hypothesis directly, we transfected activated p110α into mammary
epithelial cells while simultaneously blocking Rac activity using
NSC23766. In the presence of HGF, expression of activated p110α
resulted in longer branches than control plasmid-transfected cells
(Fig. 6D and E). However, this effect was blocked by treatment
with NSC23766 (Fig. 6D and E). These data suggest that activated
p110α induces branch extension through Rac1.
Activated Rac1 is found at the leading edge of cells in the elongating
branches
As shown by many studies, PI3K signaling through Rac1 is
important for cell motility and invasion (Ridley et al., 1992). Rac1has been implicated in establishing and maintaining the leading
edge of motile cells, and Rac1 is dynamically activated at speciﬁc
locations in the extending leading edge in different cell types
including neutrophils and T cells (Cernuda-Morollon et al., 2010;
Gardiner et al., 2002). However, no studies have reported the
localization of activated Rac1 within morphogenetic tissues. Acti-
vated GTP-bound Rac1 can be detected in whole cell lysates by
virtue of its ability to associate with the p21-binding domain (PBD)
of the Rac1 effector protein PAK. To examine the spatial localiza-
tion of activated Rac1 during branch extension, we took advantage
of a GST-PAK-PBD fusion protein which only recognizes GTP-bound
Rac1 (Cernuda-Morollon et al., 2010; Joffre et al., 2011). This in situ
analysis revealed that Rac1 was activated at the tips of the cells
leading the branches (Fig. 6F), consistent with a requirement for
the activation of this GTPase during branch extension. These data
thus suggest that activated Rac1 is spatially positioned to mediate
PI3K-induced branch extension.Discussion
Here we investigated how the PI3K pathway regulates different
steps of branching morphogenesis of mammary epithelial cells in
culture. Our results suggest that PI3K regulates branch initiation
and extension through distinct pathways (Fig. 7). High mechanical
stress leads to sustained levels of phosphorylated activated Akt at
future branch sites, and this activation is required for branch
initiation. In contrast, Rac1 is activated at the leading edge of
nascent branches and required for branch extension. The levels of
pAkt are controlled by pPTEN, which in turn is regulated by
mechanical signaling via SPRY2. Manipulating PI3K, Akt, Rac1, or
SPRY2 thus alters branching morphogenesis of cultured mammary
epithelial cells by tuning branch initiation or extension without
inducing major alterations in cell death (Fig. S5).
The PI3K pathway has also been implicated in the regulation of
branching morphogenesis of several other epithelial tissues. In a
study which used the PTENloxp/loxp; SP-C-rtTA+/-; TetO-Cre+/- mice,
loss of PTEN resulted in impaired branching morphogenesis of the
airways of the lung (Yanagi et al., 2007). Organ cultures of the
ureteric bud taken from E10.5 mouse embryos revealed that
inhibiting PI3K, but not MEK1 or p38 MAPK, completely blocks
GDNF-dependent outgrowth, which suggests that induction of the
ureteric bud requires PI3K (Tang et al., 2002). PI3K is also essential
for branching after the ureteric bud has invaded the metanephric
Fig. 4. Spatial distribution of pAkt and pPTEN is affected by altering cellular contractility. (A) Mammary epithelial tubules were treated with HGF with or without
blebbistatin or Y27632 for 2 h. Shown are immunoﬂuorescence images and frequency maps of 50 tubules stained for pAkt and pPTEN. Scale bars, 50 mm. Color bars indicate
frequency. (B, C) Average line scan of intensity of pAkt (B) or pPTEN (C) along the tubules. Po0.0001 for blebbistatin or Y27632 as compared to control.
W. Zhu, C.M. Nelson / Developmental Biology 379 (2013) 235–245 241mesenchyme, since LY294002 inhibits branching in E11.5 meta-
nephric kidneys (Tang et al., 2002). It is interesting to note that in
our 3D culture models, the PI3K pathway is necessary but not
sufﬁcient to induce branching. In the absence of growth factors,
we did not observe any branching in the tubules comprised of cells
ectopically expressing activated p110α. However, in the presence
of growth factors, activated p110α induced the extension of
signiﬁcantly longer branches. Transgenic mice overexpressing
PI3K in the mammary gland also do not display excessive ductal
branching until stimulated by hormones at puberty (Renner et al.,
2008), even though complete knockout of p110α signiﬁcantly
blocks mammary branching and ductal extension (Utermark
et al., 2012). It is therefore likely that, in parallel to PI3K, other
growth factor-induced signaling pathways are required to induce
branching morphogenesis of mammary epithelial cells.
Our data suggest an important link between PI3K signaling and
SPRY2 expression in the regulation of branching morphogenesis ofmammary epithelial cells. SPRY proteins are well appreciated as
antagonists of FGF signaling during branching morphogenesis of the
Drosophila tracheal system (Hacohen et al., 1998; Kramer et al., 1999).
In that organ, SPRY is expressed in the tip cell (the actively branching
cell) and antagonizes FGF-induced signaling in the adjacent stalk cells,
thereby inhibiting ectopic secondary branching (Hacohen et al., 1998).
Here, we found a similar pattern of expression in mammary epithelial
tubules, with high levels of SPRY2 in cells located at future branch
sites. We also found a similar inhibitory phenotype, although in this
case, SPRY2 at branch sites activates PTEN in the trunk of the tubules
(analogous to the stalk cells), thus leading to inhibition of Akt in those
cells and preventing ectopic branching. How SPRY2 accomplishes this
non-cell autonomous inhibition of branching in any organ remains a
mystery, but our data suggest its reach is wider than the MAPK
pathway previously deﬁned. Indeed, SPRY2 was recently shown to
signal through both MAPK and PI3K in the prostate epithelium
(Schutzman and Martin, 2012).
Fig. 5. Loss of SPRY2 leads to elevated levels of pPTEN and pAkt. (A) Mammary epithelial cells were transfected with scrambled shRNA (Sc) or shRNA targeting SPRY2
(shSPRY2). Levels of total and phosphorylated Akt and PTEN were analyzed by immunoblot. (B, C) Mammary epithelial cells were transfected with Sc or shSPRY2 and used to
generate mammary epithelial tubules. Tubules were treated with HGF for 2 h and stained for pAkt (B) or pPTEN (C). Scale bars, 50 mm. Color bars indicate frequency.
Po0.0001 for shSPRY2 as compared to Sc control.
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Fig. 6. Inhibiting Rac1 activity blocks branch extension. (A) Mammary epithelial tubules were treated with no growth factor (No GF) or HGF with or without the Rac1
inhibitor NSC23766 for 24 h. Shown are phase contrast images and frequency maps of 50 tubules stained for nuclei. Scale bars, 50 mm. Color bars indicate frequency.
(B) Clusters of mammary epithelial cells were embedded in collagen gel and treated with No GF, EGF or HGF with or without NSC23766 and monitored for branching after
24 h. Shown are phase contrast and ﬂuorescence images depicting nuclei (blue) and actin (green). Scale bars, 100 mm. (C) Branching in the cluster assay was quantiﬁed by
counting the percentage of clusters that branched in each well. (D) Mammary epithelial cells were transfected with pCAGEN control vector or pCAG-Myr-p110-IH plasmid.
Transfected cells were used to form tubules, which were treated with No GF or HGF with or without NSC23766 for 24 h. Shown are phase contrast images and frequency
maps of 50 tubules stained for nuclei. Scale bars, 50 mm. Color bars indicate frequency. (E) Quantiﬁcation of branch length from engineered tubules transfected with pCAGEN
or pCAG-Myr-p110-IH vector and treated with or without NSC23766. *Po0.05. (F) Staining for activated Rac1. Shown is active GTP-bound Rac1 in HGF-treated, untreated,
and GST-only control samples. Scale bars, 50 mm.
W. Zhu, C.M. Nelson / Developmental Biology 379 (2013) 235–245 243Since the initial identiﬁcation of SPRY in Drosophila, four
mammalian SPRY proteins (SPRY1–4) have been discovered based
on sequence similarity (Edwin et al., 2009; Guy et al., 2009). The
expression of SPRY1, 2 and 4 is ubiquitous in both embryos and
adults, whereas SPRY3 is restricted to the brain and testes(Leeksma et al., 2002; Minowada et al., 1999; Panagiotaki et al.,
2010). Though evidence suggests that RTK signaling regulates the
expression levels of SPRY2 (Cabrita and Christofori, 2008), it is not
clear whether other types of regulation are involved. Our data
suggest a novel and prominent role for endogenous mechanical
Fig. 7. Roles of Akt, Rac1, PTEN, and SPRY2 in mammary epithelial branching
morphogenesis. (A) pAkt at the ends of the tubules is required for branch initiation.
In contrast, Rac1 is activated at the leading edge of nascent branches and required
for branch extension. (B) High mechanical stress leads to high levels of SPRY2 at
future branch sites, which leads to dephosphorylation and activation of PTEN along
the trunk of the tissue. This in turn results in less pAkt in the body of the tubules,
thus blocking ectopic branching from this location.
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presence of calyculin A, which enhances cytoskeletal contractility, and
decreases in the presence of blebbistatin, which reduces contractility
(Fig. S6). Although mechanical stress is well appreciated to regulate
signal transduction and gene expression in several tissues, its effects
on SPRY proteins are only beginning to be uncovered. SPRY1 is
upregulated following mechanical loading in the heart (Huebert et al.,
2004), and mechanical strain results in increased expression of
Spred2, a SPRY-related protein, in osteoblasts (Ott et al., 2009). Our
data suggest that mechanical stress regulates the expression of SPRY2
in mammary epithelial cells, thus controlling PTEN activation, Akt
phosphorylation, and branch initiation. Global changes in tissue
contractility lead to concentrated spatial patterns of mechanical stress
(Gjorevski and Nelson, 2010), which explains why mechanical stress
and the PI3K pathway are linked speciﬁcally and preferentially at
branch sites. It will be interesting to determine precisely how
mechanical stress alters the expression of SPRY2, both in the context
of normal morphogenesis as well as in disease.
In summary, the work presented here demonstrates that the PI3K
pathway integrates biochemical signaling from growth factors with
mechanical signaling from endogenous cytoskeletal contractility to
regulate the branching morphogenesis of mammary epithelial cells in
culture. Given the subtle differences between conditions and the fact
that pathways appear to intersect in a time-dependent manner
during branching morphogenesis (Lee et al., 2011), we expect that
the integration between these signaling pathways is complex. The
ability to parse spatial and temporal changes in signaling is a key
advantage of 3D epithelial culture models such as those used here;
these simpliﬁed systems recapitulate many aspects of mammary
epithelial morphogenesis (Lo et al., 2012; Nelson and Bissell, 2005),
but lack the heterogeneous mesenchymal environment that also
contributes to development of native tissues. Future studies exploring
how PI3K and mechanical signaling are speciﬁcally regulated and
how they work together to deﬁne the pattern of branching in vivo
will provide insight into their respective roles during physiological
and pathological development.Acknowledgments
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